Larvol Delta - BioPath-Announces-Clinical-Update-to-Interim-Analysis-of-Phase-2-Prexigebersen-Trial-in-Acute-Myeloid-Leukemia

prexigebersen (BP1001) - Bio-path

http://globenewswire.com/news-release/2019/03/06/1748809/0/en/Bio-Path-Announces-Clinical-Update-to-Interim-Analysis-of-Phase-2-Prexigebersen-Trial-in-Acute-Myeloid-Leukemia.html

Mar 6, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next